NCT06212050View on ClinicalTrials.gov

Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

June 30, 2024

Conditions
Aortic StenosisTranscatheter Aortic Valve ImplantationBicuspid Aortic ValveTranscatheter Aortic Valve Replacement
Interventions
DEVICE

Transcatheter Aortic Valve Implantation

TAVI in patients with severe BAV stenosis using ACURATE neo2

Trial Locations (3)

Unknown

Kerckhoff Heart and Lung Centre, Bad Nauheim

Galway University Hospital, Galway

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Galway University Hospitals

UNKNOWN

collaborator

CORRIB Research Centre for Advanced Imaging and Core Lab, Galway, Ireland

UNKNOWN

collaborator

Karolinska University Hospital

OTHER

collaborator

Kerckhoff Heart Center

OTHER

lead

National University of Ireland, Galway, Ireland

OTHER